Search results
Results from the WOW.Com Content Network
Cardiologist Helen B. Taussig learned of the damaging effects of the drug thalidomide on newborns and in 1967, testified before Congress on this matter after a trip to Germany where she worked with infants with phocomelia (severe limb deformities). As a result of her efforts, thalidomide was banned in the United States and Europe. [45]
Fifty years ago, the sedative Thalidomide was withdrawn after thousands of mothers gave birth to disabled babies. That ageing Thalidomide generation now faces rising care bills - but some hope...
A trove of archival records shows how in the early 1960s the Food and Drug Administration investigated the use of a drug that caused severe birth defects.
How the thalidomide scandal led to safer drugs. Between 1957 and 1962, more than 10,000 babies were born with physical abnormalities caused by the drug thalidomide. Out of this came stricter ...
A group of thalidomide survivors in the state of North Rhine-Westphalia has invited people to a celebration of life in Cologne to defiantly show that they are still here and alive.
Gruenthal employed actual Nazis—one of thalidomide’s key developers had experimented on prisoners at Auschwitz and Buchenwald, killing hundreds. At one point Vanderbes openly wonders if thalidomide was first formulated in the camps.
In the 1960s, FDA inspector Frances Kelsey was assigned her first drug to review: thalidomide. Her thorough investigation led her to discover that the drug had caused pregnant women to bear...
In this longer read, medical historian Arthur Daemmrich sets the scene of the mid-20th century drug landscape and explains how thalidomide was marketed, used, and withdrawn after causing...
The thalidomide scandal stands as one of the worst ever medical disasters. The sedative, created in Germany in 1953 and marketed as a powerful antiemetic to pregnant women, led to 2000 deaths and to 10 000 children with birth defects, principally in Europe, Australasia, and Canada.
In the U.S. in the early 1960s the distributor of a thalidomide drug was impatient to get it on the market. But FDA medical examiner Frances Oldham Kelsey wanted more information to prove its...